Found: 13
Select item for more details and to access through your institution.
Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative Analysis of <sup>18</sup>F-FDG PET/CT and Conventional CT Imaging.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266925
- By:
- Publication type:
- Article
Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative Analysis of <sup>18</sup>F-FDG PET/CT and Conventional CT Imaging.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 845, doi. 10.2967/jnumed.123.266925
- By:
- Publication type:
- Article
Long-Term Nephrotoxicity of <sup>177</sup>Lu-PSMA Radioligand Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 79, doi. 10.2967/jnumed.123.265986
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 0, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 0, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article